Logan D - Search Results

1

Canadian women's attitudes towards breast cancer gene testing.

Cappelli M, Surh L, Verma S, Ryan W, Logan D, Korneluk Y, Feeny D, Hunter A, Allanson J. Cappelli M, et al. Among authors: logan d. Am J Hum Genet. 1997 Oct;61(4):A187. Am J Hum Genet. 1997. PMID: 11644962 No abstract available.

2

Psychological and social determinants of women's decisions to undergo genetic counseling and testing for breast cancer.

Cappelli M, Surh L, Humphreys L, Verma S, Logan D, Hunter A, Allanson J. Cappelli M, et al. Among authors: logan d. Clin Genet. 1999 Jun;55(6):419-30. doi: 10.1034/j.1399-0004.1999.550605.x. Clin Genet. 1999. PMID: 10450858

3

Measuring women's preferences for breast cancer treatments and BRCA1/BRCA2 testing.

Cappelli M, Surh L, Humphreys L, Verma S, Logan D, Hunter A, Allanson J. Cappelli M, et al. Among authors: logan d. Qual Life Res. 2001;10(7):595-607. doi: 10.1023/a:1013123915272. Qual Life Res. 2001. PMID: 11822793

4

Breast cancer: better care for less cost. Is it possible?

Evans WK, Will BP, Berthelot JM, Logan DM, Mirsky DJ, Kelly N. Evans WK, et al. Among authors: logan dm. Int J Technol Assess Health Care. 2000 Autumn;16(4):1168-78. doi: 10.1017/s0266462300103204. Int J Technol Assess Health Care. 2000. PMID: 11155836

5

How interested is the public in genetic testing for colon cancer susceptibility? Report of a cross-sectional population survey.

Graham ID, Logan DM, Hughes-Benzie R, Evans WK, Perras H, McAuley LM, Laupacis A, Stern H. Graham ID, et al. Among authors: logan dm. Cancer Prev Control. 1998 Aug;2(4):167-72. Cancer Prev Control. 1998. PMID: 10093629

6

Oral etoposide and carboplatin. Effective therapy for elderly patients with small cell lung cancer.

Evans WK, Radwi A, Tomiak E, Logan DM, Martins H, Stewart DJ, Goss G, Maroun JA, Dahrouge S. Evans WK, et al. Among authors: logan dm. Am J Clin Oncol. 1995 Apr;18(2):149-55. Am J Clin Oncol. 1995. PMID: 7534977 Clinical Trial.

7

Addition of pentoxifylline plus nifedipine to chemotherapy in patients with cisplatin-resistant cancers of the lung and other sites.

Stewart DJ, Evans WK, Logan D. Stewart DJ, et al. Among authors: logan d. Am J Clin Oncol. 1994 Aug;17(4):313-6. doi: 10.1097/00000421-199408000-00006. Am J Clin Oncol. 1994. PMID: 8048393

8

Phase II study of flutamide in patients with metastatic breast cancer. A National Cancer Institute of Canada Clinical Trials Group study.

Perrault DJ, Logan DM, Stewart DJ, Bramwell VH, Paterson AH, Eisenhauer EA. Perrault DJ, et al. Among authors: logan dm. Invest New Drugs. 1988 Sep;6(3):207-10. doi: 10.1007/BF00175399. Invest New Drugs. 1988. PMID: 3192386

9

Lung cancer practice guidelines: lessons learned and issues addressed by the Ontario Lung Cancer Disease Site Group.

Evans WK, Newman T, Graham I, Rusthoven JJ, Logan D, Shepherd FA, Chamberlain D. Evans WK, et al. Among authors: logan d. J Clin Oncol. 1997 Sep;15(9):3049-59. doi: 10.1200/JCO.1997.15.9.3049. J Clin Oncol. 1997. PMID: 9294467

10

A phase II study of ifosfamide in combination with etoposide and cisplatin in the treatment of extensive small cell lung cancer.

Evans WK, Stewart D, Logan D, Maroun J, Goss G, Shepherd FA, Latreille J, Warner E, Dahrouge S. Evans WK, et al. Among authors: logan d. Semin Oncol. 1992 Dec;19(6 Suppl 12):51-6. Semin Oncol. 1992. PMID: 1336622 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

662 results

Search Page

Filters